The Jimmy Fund reposted this
Laurie H. Glimcher, MD, Dana-Farber Cancer Institute President and CEO, announced today that she will step down after 8 highly successful years, on October 1, 2024, and will assume the title of President Emerita. Benjamin Levine Ebert, MD, PhD, chair of Department of Medical Oncology and a world-renowned medical oncologist and researcher, was appointed by the Board of Trustees to serve as the next president and CEO of Dana-Farber effective October 1. The seventh president of Dana-Farber and the first woman to lead the organization in its 77-year history, Glimcher began her tenure in October 2016 with a relentless focus on improving outcomes for patients and accelerating cancer drug development. Dana-Farber is credited for playing a critical role in the development of 51% of all cancer drugs approved by the U.S. Food and Drug Administration over the past five years. “Eight years ago, I began this journey with a deep appreciation for the extraordinary research that emanated from Dana-Farber since its earliest days and the clinical excellence that Dana-Farber provides patients and families,” said Glimcher. “And now, as I reflect on my tenure, I am intensely proud of what we have achieved in providing world class care for our patients, leading in innovation and discovering new treatments and cures.” Glimcher will continue her pioneering cancer immunology research at Dana-Farber and build on her legacy of mentoring young cancer scientists. Read more here: https://lnkd.in/gn4Ekd77 Laurie Glimcher Benjamin L. Ebert, MD, PhD